These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8387764)
1. Risk of liver disease in HCV-seropositive kidney transplant recipients. Rohr MS; Lesniewski RR; Rubin CA; Johnson RG; Heise ER; McDonald JC; Adams PL Ann Surg; 1993 May; 217(5):512-6; discussion 516-7. PubMed ID: 8387764 [TBL] [Abstract][Full Text] [Related]
2. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of viral hepatitis in solid organ transplantation]. Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection among kidney transplant recipients. Ponz E; Campistol JM; Bruguera M; Barrera JM; Gil C; Pinto JB; Andreu J Kidney Int; 1991 Oct; 40(4):748-51. PubMed ID: 1720826 [TBL] [Abstract][Full Text] [Related]
5. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Huang CC; Liaw YF; Lai MK; Chu SH; Chuang CK; Huang JY Transplantation; 1992 Apr; 53(4):763-5. PubMed ID: 1373534 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Orloff SL; Stempel CA; Wright TL; Tomlanovich SJ; Amend WJ; Stock PG; Melzer JS; Vincenti F Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity? Gessoni G; Manoni F Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation. Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631 [TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation]. Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H Presse Med; 1991 Nov; 20(40):2025-7. PubMed ID: 1837117 [TBL] [Abstract][Full Text] [Related]
10. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918 [TBL] [Abstract][Full Text] [Related]
11. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation. Yuan CH; Liu YF; Li GC Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755 [TBL] [Abstract][Full Text] [Related]
12. A prospective study of hepatitis C viremia in renal allograft recipients. Mahmoud IM; Sobh MA; Amer GM; El-Chenawy FA; Gazareen SH; El-Sherif A; El-Sawy E; Ghoneim MA Am J Nephrol; 1999; 19(5):576-85. PubMed ID: 10575187 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients. Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB Nephron; 1995; 70(4):397-401. PubMed ID: 7477642 [TBL] [Abstract][Full Text] [Related]
14. The impact of hepatitis C virus infection on liver disease in renal transplant recipients. Fujimoto N; Kyo M; Ichikawa Y; Fukunishi T; Nagano S Transpl Int; 1994; 7 Suppl 1():S346-9. PubMed ID: 11271248 [TBL] [Abstract][Full Text] [Related]
15. Clinical course of concomitant Hbv and Hcv infection in renal allograft recipients. Durlik M; Gaciong Z; Soluch L; Rancewicz Z; Rowińska D; Kozłowska-Boszko B; Wyzga J; Walewska-Zielecka B; Rowiński W; Szmidt J; Lao M Ann Transplant; 1996; 1(2):11-2. PubMed ID: 9869922 [TBL] [Abstract][Full Text] [Related]
16. [Hepatitis C virus and renal transplantation]. Fabrizi F; Martin P; Lunghi G; Aroldi A; Messa PG G Ital Nefrol; 2004; 21(5):429-37. PubMed ID: 15547874 [TBL] [Abstract][Full Text] [Related]
17. Detection of antibody to hepatitis C virus in renal transplant recipients. Roth D; Fernandez JA; Burke GW; Esquenazi V; Miller J Transplantation; 1991 Feb; 51(2):396-400. PubMed ID: 1847250 [TBL] [Abstract][Full Text] [Related]
18. Histopathological impacts of hepatitis virus infection in hemodialysis patients: should liver biopsy be performed before renal transplantation? Ozdoğan M; Ozgür O; Gür G; Boyacioğlu S; Ozderin Y; Demirhan B; Telatar H; Haberal M Artif Organs; 1997 May; 21(5):355-8. PubMed ID: 9129765 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to hepatitis C virus in patients with various types of liver diseases. Kim KH; Lee HR; Min CH; Jeong H; Hong SH; Lee YS; Cha YJ; Yoo BC; Park SM Korean J Intern Med; 1992 Jan; 7(1):9-12. PubMed ID: 1282365 [TBL] [Abstract][Full Text] [Related]
20. The impact of hepatitis C virus infection on renal allograft recipients. Roth D; Zucker K; Cirocco R; DeMattos A; Burke GW; Nery J; Esquenazi V; Babischkin S; Miller J Kidney Int; 1994 Jan; 45(1):238-44. PubMed ID: 7510350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]